Evidence map›Paper›PMID 37396923›Full record

ArticleFrontiers in cellular neuroscience2023

The ferroptosis inducer RSL3 triggers interictal epileptiform activity in mice cortical neurons.

Michela Giustizieri, Sara Petrillo, Jessica D'Amico, Caterina Torda, Andrea Quatrana, Federico Vigevano, Nicola Specchio, Fiorella Piemonte, Enrico Cherubini

Abstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. DIRAS2 modulates MAPK pathway-mediated ferroptosis to regulate excitation/inhibition balance and seizure susceptibility.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Michela GiustizieriEuropean Brain Research Institute (EBRI)-Rita Levi-Montalcini Foundation, Rome, Italy.
Sara PetrilloMuscular and Neurodegenerative Diseases Laboratory, Research Area of Neurological Sciences and Rehabilitation Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Jessica D'AmicoMuscular and Neurodegenerative Diseases Laboratory, Research Area of Neurological Sciences and Rehabilitation Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Caterina TordaMuscular and Neurodegenerative Diseases Laboratory, Research Area of Neurological Sciences and Rehabilitation Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Andrea QuatranaMuscular and Neurodegenerative Diseases Laboratory, Research Area of Neurological Sciences and Rehabilitation Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Federico VigevanoNeurology Unit, Research Area of Neurological Sciences and Rehabilitation Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Nicola SpecchioClinical and Experimental Neurology, Bambino Gesù Children's Hospital, IRCCS, Full Member of European Reference Network on Rare and Complex Epilepsies (EpiCARE), Rome, Italy.
Fiorella PiemonteMuscular and Neurodegenerative Diseases Laboratory, Research Area of Neurological Sciences and Rehabilitation Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Enrico CherubiniEuropean Brain Research Institute (EBRI)-Rita Levi-Montalcini Foundation, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epilepsy is a neurological disorder characterized by recurrent seizures, which result from excessive, synchronous discharges of neurons in different brain areas. In about 30% of cases, epileptic discharges, which vary in their etiology and symptomatology, are difficult to treat with conventional drugs. Ferroptosis is a newly defined iron-dependent programmed cell death, characterized by excessive accumulation of lipid peroxides and reactive oxygen species. Evidence has been provided that ferroptosis is involved in epilepsy, and in particular in those forms resistant to drugs. Here, whole cell patch clamp recordings, in current and voltage clamp configurations, were performed from layer IV principal neurons in cortical slices obtained from adult mouse brain. Application of the ferroptosis inducer RAS-selective lethal 3 (RSL3) induced interictal epileptiform discharges which started at RSL3 concentrations of 2 μM and reached a plateau at 10 μM. This effect was not due to changes in active or passive membrane properties of the cells, but relied on alterations in synaptic transmission. In particular, interictal discharges were dependent on the excessive excitatory drive to layer IV principal cells, as suggested by the increase in frequency and amplitude of spontaneously occurring excitatory glutamatergic currents, possibly dependent on the reduction of inhibitory GABAergic ones. This led to an excitatory/inhibitory unbalance in cortical circuits. Interictal bursts could be prevented or reduced in frequency by the lipophilic antioxidant Vitamin E (30 μM). This study allows identifying new targets of ferroptosis-mediated epileptic discharges opening new avenues for the treatment of drug-resistant forms of epilepsy.

Indexed as

disinhibitionE/I unbalanceepilepsyFerroptosisGABAergic and Glutamatergic signalinginterictal dischargesneurodevelopmental disordersRSL3

Identifiers

PMID37396923
PMCPMC10311487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.